Pipeline Watch: Phase III Starts With AL001, Beremagene Geperpavec And Relacorilant

Two COVID-19 Vaccines Start Phase III

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.    

Pipeline Watch regular column feature image

Open Media

The table above records the past week's changes to the progress of selected potential new products through the clinical trial pipeline, using data from Informa Pharma Intelligence's Biomedtracker

More from Pipeline Watch

More from R&D